Why the study?
The study was conducted to appraise autonomic impairment through examination of time-domain and frequency-domain heart rate variability parameters in individuals with epilepsy.
Does epilepsy alter heart rate variability parameters compared to healthy controls?
Does epilepsy alter heart rate variability parameters compared to healthy controls?
Patients with epilepsy exhibit altered frequency-domain heart rate variability parameters, suggesting increased sympathetic and decreased parasympathetic activity, which may be related to the risk of sudden unexpected death in epilepsy (SUDEP).
Altered HRV in epilepsy may flag SUDEP vulnerability; hypothesis-generating and should not yet change practice.
Objective: The objective of this research was to appraise autonomic impairment through the examination of both time-domain and frequency-domain parameters of heart rate variability in individuals with epilepsy. Methods: Thirty epilepsy patients and thirty healthy subjects were enrolled in our study for evaluation of autonomic functions, which was assessed by comparing heart rate variability between epilepsy patients and healthy subjects. Results: There was no notable disparity observed in mean heart rate between the two groups. However, the frequency-domain metrics-LF Power, HF Power, and LF/HF ratio exhibited statistically noteworthy differences when comparing the patients to the control group (p-value<0.05). Conversely, parameters such as SDNN, RMSST, and pNN50 did not demonstrate statistically considerable differences in comparison to the controls (p-value>0.05). The parameters did not exhibit statistically significant distinctions between individuals with epilepsy for under 10 y and those diagnosed with epilepsy for over 10 y. Conclusion: Our investigation revealed a notable contrast in HRV metrics between the patient group and the group of individuals in good health. The potential utilization of HRV as an indicator of susceptibility to SUDEP could enhance the quality of guidance provided to both patients and their families. Additional exploration is warranted, involving more extensive participant cohorts, and examining the impact of antiepileptic medications on HRV, within future studies.
No takes yet. Share an insight, caveat, or question.
Rashmi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: